Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises in connection with sale of shares in Advania AB
Mandate

Vinge advises in connection with sale of shares in Advania AB

September 10, 2018 Capital Markets and Public M&A

Vinge advises the existing shareholders in Advania AB In connection with their sale of shares in Advania to Via Equity and PFA, the largest commercial pension company in Denmark.

Advania is a Nordic IT company with business in Sweden, Iceland, Norway and Denmark, who helps its customer to simplify IT infrastructures, enhance performance and cut costs.

Vinge’s team consisted of responsible partner Peter Sundgren and associates Oscar Rydén and Anna Thoms, as well as counsel Maria Schultzberg.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026